Hydromorphone Hydrochloride
Active substance: hydromorphone
INJECTION, SOLUTION · HYDROMORPHONE HYDROCHLORIDE 10 mg/mL
United StatesActive
Marketing holder: Teva Parenteral Medicines, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- HYDROMORPHONE HYDROCHLORIDE · 10 mg/mL
Import and control
Control by country
- United StatescontrolledSchedule: CII
Source: openFDA NDC · record 01a1208c-304d-785e-9ee0-35757f5e3376,01a1208c-38a9-71a5-9356-5623fef88602,01a1208c-3932-7938-9f06-d341cf3cf050,01a1208c-489c-7030-8e96-834a9a9539eb,01a1208c-4fcf-79ec-8a32-ba9d3a2655ed;count=72 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0703-0110
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CII
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Sources
- product · openFDA NDC · 0703-0110 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0703-0110 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0703-0110 · Verified 2026-10-09 · open in source